iShares U.S. Pharmaceuticals ETF is a ETF series of iShares Trust (series S000009417). Net assets $1.0B as of 2026-03-31. Index fund.
Showing 15 of 59 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| JOHNSON & JOHNSON | — | $230.4M | 2302.75% |
| ELI LILLY AND COMPANY | — | $210.7M | 2105.77% |
| MERCK & CO., INC. | — | $47.4M | 473.89% |
| PFIZER INC. | — | $47.1M | 470.90% |
| ROYALTY PHARMA PLC | — | $47.1M | 470.37% |
| BRISTOL-MYERS SQUIBB COMPANY | — | $46.3M | 462.93% |
| ZOETIS INC. | — | $45.2M | 451.78% |
| BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | — | $43.6M | 435.55% |
| VIATRIS INC. | — | $43.5M | 434.64% |
| ELANCO ANIMAL HEALTH INCORPORATED | — | $33.2M | 332.12% |
| JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY | — | $32.1M | 320.88% |
| AXSOME THERAPEUTICS, INC. | — | $20.0M | 199.93% |
| Terns Pharmaceuticals Inc | — | $12.7M | 126.68% |
| LIGAND PHARMACEUTICALS INCORPORATED | — | $11.0M | 109.76% |
| INDIVIOR PHARMACEUTICALS, INC. | — | $10.6M | 106.30% |
| Report date | Net assets |
|---|---|
| 2026-03-31 | $1.0B |
| 2025-12-31 | $847.7M |
| 2025-09-30 | $580.8M |
| 2025-06-30 | $550.5M |
| 2025-03-31 | $617.3M |
| 2024-12-31 | $610.6M |
| 2024-09-30 | $660.1M |
| 2024-06-30 | $683.5M |